Cite
MicroRNA-149 rs2292832 C/T Polymorphism Predicts the Prognosis of Hepatocellular Carcinoma Patients With Bone Metastasis.
MLA
Feng, Jian, et al. “MicroRNA-149 Rs2292832 C/T Polymorphism Predicts the Prognosis of Hepatocellular Carcinoma Patients With Bone Metastasis.” Laboratory Medicine, vol. 53, no. 6, Nov. 2022, pp. 561–69. EBSCOhost, https://doi.org/10.1093/labmed/lmac036.
APA
Feng, J., Liu, Z., Yu, L., Wu, C., & Luo, X. (2022). MicroRNA-149 rs2292832 C/T Polymorphism Predicts the Prognosis of Hepatocellular Carcinoma Patients With Bone Metastasis. Laboratory Medicine, 53(6), 561–569. https://doi.org/10.1093/labmed/lmac036
Chicago
Feng, Jian, Zhen Liu, Long Yu, Chaoyu Wu, and Xiao-bo Luo. 2022. “MicroRNA-149 Rs2292832 C/T Polymorphism Predicts the Prognosis of Hepatocellular Carcinoma Patients With Bone Metastasis.” Laboratory Medicine 53 (6): 561–69. doi:10.1093/labmed/lmac036.